CIVI
Civitas Resources Inc
Civitas Resources Inc historical holders
total: 5
Oaktree Capital Management Civitas Resources Inc transactions over time
- Total transactions:
- 19
- New positions:
- 3
- Sold out:
- 3
- Added:
- 4
- Reduced:
- 9
- Held since:
- 2021 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2023 Q1
Howard Marks has been an institutional investor in Civitas Resources Inc (CIVI) since 2017 Q2. According to 2026 Q1 report, Howard Marks doesn't hold any shares. The fund/company first acquired CIVI in 2017 Q2, initially purchasing 525,900 shares. Howard Marks later completely sold out the position and reinvested in CIVI again in 2021 Q4. Since the initial investment, Oaktree Capital Management has made 18 more transactions in this position.
When did Howard Marks exit their CIVI position?
Howard Marks no longer holds Civitas Resources Inc (CIVI). They sold off their entire position in 2023 Q1, closing out an investment that began in 2017 Q2.
When did Howard Marks first invest in CIVI?
Howard Marks first invested in Civitas Resources Inc (CIVI) in 2017 Q2 at the reported quarter-end price of $31.71 per share, acquiring 525,900 shares in their initial purchase.
What is Howard Marks's average cost basis for CIVI?
Based on historical transaction data, Howard Marks's estimated cost basis for Civitas Resources Inc (CIVI) is approximately $48.97 per share. This represents their average reported price* across all buy transactions.
Has Howard Marks reinvested in CIVI after selling?
Yes, Howard Marks has shown renewed interest in Civitas Resources Inc (CIVI). After completely selling their position, they reinitiated an investment in 2021 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $48.97
- Weighted AVG sell price:
- $58.03
CIVI transactions history by Oaktree Capital Management
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
0.00%
|
0
|
$57.93
|
|
-100% (-115,000)
|
-0.07%
|
|
2022 Q4
|
0.07%
|
115,000
|
$57.93
|
$6,661,950
|
-90.00% (-1,035,000)
|
-0.68%
|
|
2022 Q3
|
0.75%
|
1,150,000
|
$57.39
|
$65,998,000
|
-3.20% (-38,000)
|
-0.03%
|
|
2022 Q2
|
0.74%
|
1,188,000
|
$52.29
|
$62,120,000
|
-1.00% (-12,000)
|
-0.01%
|
|
2022 Q1
|
0.76%
|
1,200,000
|
$59.71
|
$71,652,000
|
-9.35% (-123,788)
|
-0.09%
|
|
2021 Q4
|
0.75%
|
1,323,788
|
$48.97
|
$64,825,000
|
new
|
+0.75%
|
|
2020 Q3
|
0.00%
|
$14.79
|
-100% (-28,000)
|
|||
|
2020 Q2
|
0.01%
|
$14.79
|
-96.23% (-713,726)
|
|||
|
2020 Q1
|
0.24%
|
$11.25
|
-26.32% (-265,000)
|
|||
|
2019 Q4
|
0.46%
|
$23.34
|
-21.56% (-276,726)
|
|||
|
2019 Q3
|
0.59%
|
$22.39
|
-19.10% (-302,931)
|
|||
|
2019 Q2
|
0.67%
|
$20.88
|
-6.69% (-113,773)
|
|||
|
2018 Q4
|
0.67%
|
$20.67
|
+197.64% (+1,128,948)
|
|||
|
2018 Q3
|
0.28%
|
$29.78
|
+59.35% (+212,752)
|
|||
|
2018 Q2
|
0.19%
|
$37.87
|
+49.53% (+118,732)
|
|||
|
2018 Q1
|
0.11%
|
$27.71
|
new
|
|||
|
2017 Q4
|
0.00%
|
$32.99
|
-100% (-526,173)
|
|||
|
2017 Q3
|
0.26%
|
$32.99
|
+0.05% (+273)
|
|||
|
2017 Q2
|
0.27%
|
$31.71
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.